Orum Therapeutics, Inc. (KOSDAQ:475830)
82,200
+500 (0.61%)
At close: Dec 5, 2025
| Market Cap | 1.74T |
| Revenue (ttm) | 25.48M |
| Net Income (ttm) | -36.88B |
| Shares Out | 21.16M |
| EPS (ttm) | -2,048.72 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 793,509 |
| Average Volume | 393,170 |
| Open | 81,600 |
| Previous Close | 81,700 |
| Day's Range | 74,500 - 84,500 |
| 52-Week Range | 15,950 - 84,500 |
| Beta | n/a |
| RSI | 81.51 |
| Earnings Date | Nov 14, 2025 |